BMED vs HELX: Holdings Overlap & Returns

Over the year to Nov 13, 2026, BMED returned +25.4% to HELX's +22.6%; 12% of their weight is in the same names.

Return gap
+2.8 pts1 year to Nov 13, 2026: BMED ahead, total return
Fee gap
0.05 ptsA year: BMED 0.55%, HELX 0.50%, per filings dated Nov 21, 2025 and Jul 27, 2026
Overlap
12%Share of the two books held in common, holdings dated Nov 12, 2026 and Jun 30, 2026
Net flow
–Needs daily flows for both funds
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
BMED and HELX · 1 year

Growth of 100

BMED +25.4%HELX +22.6%
Growth of 100 in BMED and HELX over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. BMED ends at 125.4 (+25.4%), HELX at 122.6 (+22.6%).

BMED +25.4%, HELX +22.6%: BMED +2.8 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Alert

BMED flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag the order size

Cost to trade

Hypothetical. A $10,000 order in BMED costs about $11.50 one way and $23.00 in and out, at a median spread of 0.23%. The 0.23% spread is BMED’s 30-day median, from iShares (fund page).

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in BMED for 10 years at 0.55% a year costs about $908 in fees and lost growth; HELX at 0.50% would cost $827. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

BMED · 1 year to Nov 13, 202642% of its weight is outside the S&P 500
42% of its weight is outside the S&P 50058% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.58%42%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 96% · top ten 44% of the fund · 55 holdings as published by its issuer for Nov 12, 2026 · Nasdaq-100: 14% in42% of its weight is outside the S&P 50058% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.58%42%in the S&P 500outsideactive share 96% · Nasdaq-100: 14% in

58% of BMED's weight is in S&P 500 companies and 42% is outside the index. Holdings as of Nov 12, 2026.

HELX · 1 year to Nov 13, 202685% of its weight is outside the S&P 500
85% of its weight is outside the S&P 50015% of HELX's weight is in S&P 500 companies and 85% is outside the index. Holdings as of Jun 30, 2026.15%85%in the S&P 500of its weight outside the S&P 500active share 97% · top ten 47% of the fund · 61 holdings as filed for Jun 30, 2026 · Nasdaq-100: 8% in85% of its weight is outside the S&P 50015% of HELX's weight is in S&P 500 companies and 85% is outside the index. Holdings as of Jun 30, 2026.15%85%inof its weight outside the S&P 500active share 97% · Nasdaq-100: 8% in

15% of HELX's weight is in S&P 500 companies and 85% is outside the index. Holdings as of Jun 30, 2026.

Key numbers

BMED in the S&P 500
58.2%
HELX in the S&P 500
14.9%
BMED total return, 1 year
+25.4%
HELX total return, 1 year
+22.6%

HELX costs 0.05 points a year less; their one-year returns differ by 2.8 points; HELX is 2.3 times larger.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year+25.4%+22.6%
Below its all-time high26.5%, high on Sep 7, 2021
What it tracksHealthcare innovation and GLP-1Healthcare innovation and GLP-1
Expense ratio0.55%0.50%
Net assets, as of Nov 12, 2026$15m$34m
Holdings in common12%

The numbers behind it

Net assets: $15m on Nov 13, 2026 for iShares Health Innovation Active ETF, and $34m on Nov 12, 2026 for Franklin Genomic Advancements ETF.

Holdings in common uses holdings dated Jun 30, 2026 and Nov 12, 2026.

What they share

By the books each fund has filed, BMED and HELX hold 12% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Nov 12, 2026.

0half (50%)100%

half

12% in common

Held in common

Show all 12 holdings
VERTEX PHARMACEUTICALS3.29%2.75%
NEUROCRINE BIOSCIENCES2.31%1.84%
CHARLES RIVER LABORATORIES INTERNA1.61%1.26%
GUARDANT HEALTH1.24%9.09%
TEMPUS AI CLASS A0.91%1.95%
THERMO FISHER SCIENTIFIC4.33%0.76%
IQVIA HOLDINGS INC3.58%0.75%
AXSOME THERAPEUTICS0.71%0.82%
AGILENT TECHNOLOGIES INC2.34%0.58%
DANAHER5.15%0.57%
PTC THERAPEUTICS0.44%1.46%
BRISTOL MYERS SQUIBB1.31%0.25%

Only in BMED

Show all 8 holdings
GILEAD SCIENCES5.80%
MODERNA5.52%
ABBVIE4.91%
EDWARDS LIFESCIENCES4.25%
BIOGEN3.70%
METTLER-TOLEDO INTERNATIONAL INC3.61%
MERCK & CO INC2.97%
ROCHE PS PAR AG2.85%

Only in HELX

Show all 8 holdings
NATERA INC7.46%
KRYSTAL BIOTECH INC6.33%
LIGAND PHARMACEUTICALS INC4.62%
ADAPTIVE BIOTECHNOLOGIES CORP3.99%
UNITED THERAPEUTICS CORP3.51%
BRIDGEBIO PHARMA INC3.50%
ELI LILLY & COMPANY2.95%
TWIST BIOSCIENCE CORP2.85%

Side by side

Open the table
FundiShares Health Innovation Active ETF · Holds 55 stocks in healthcare innovation and GLP-1, 58% of its weight in S&P 500 companiesFranklin Genomic Advancements ETF · Holds 61 stocks in healthcare innovation and GLP-1, 15% of its weight in S&P 500 companies
IssueriSharesFranklin
ThemeHealthcare innovation and GLP-1Healthcare innovation and GLP-1
In the S&P 50058.2%14.9%
Active share vs the S&P 50095.6%97.2%
In the Nasdaq-10013.8%7.5%
Holdings5561
Top ten, share of the fund44.1%47.1%
Expense ratio0.55%0.50%
Fee for the differing part0.58%0.51%
Total return, 1 year+25.4%+22.6%
vs its benchmarknot measurednot measured
Below its high−2.7%−26.5%
Net assets, BMED as of Nov 13, 2026 and HELX as of Nov 12, 2026$15m$34m

As of Nov 13, 2026. Source: ETFIQ.

Window by window

Open the table
3 months+12.9%+5.0%
6 months+33.6%+29.7%
1 year+25.4%+22.6%
3 years+68.1%+57.1%
Since launch (Not the same days: BMED Oct 2020 · HELX Feb 2020)+42.8%+78.8%

About BMED

By weight, 58% of BMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 96%. The top ten holdings are 44% of the fund across 55 positions, as published by its issuer for Nov 12, 2026.

More

Over the year to Nov 13, 2026 the fund returned +25.4% with distributions reinvested.

About HELX

By weight, 15% of HELX's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 47% of the fund across 61 positions, as filed for Jun 30, 2026.

More

Over the year to Nov 13, 2026 the fund returned +22.6% with distributions reinvested. It sits 26.5% below its all-time high of Sep 7, 2021.

12% of the two portfolios are the same securities at the same weight.

Questions people ask

Do BMED and HELX hold the same stocks?

By their latest filings, 12% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, BMED or HELX?

BMED has 58% of its weight in S&P 500 names and HELX has 15%, so HELX differs more from the index.

Which is cheaper, BMED or HELX?

BMED charges 0.55% a year and HELX charges 0.50%, so HELX is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, BMED against HELX, data as of Nov 13, 2026. https://etfiq.com/compare/themes/bmed-vs-helx

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.